Skip to main content
main-content

Zeitschrift

Journal of Thrombosis and Thrombolysis

Journal of Thrombosis and Thrombolysis 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 34 Artikel )

01.08.2020 | Ausgabe 2/2020

The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials

Xianbin Yu, Jinwu Wang, Xingyu Wang, Linzhen Xie, Chunhui Chen, Wenhao Zheng

19.01.2020 | Ausgabe 2/2020

Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life

Azza A. Tantawy, Nayera H. K. Elsherif, Mahmoud A. Kenny, Khaled A. Aboulfotouh, Ahmed E. Hassan, Marwa E. Kabil

24.06.2020 | Ausgabe 2/2020

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Jeffrey I. Weitz, Sylvia Haas, Walter Ageno, Samuel Z. Goldhaber, Alexander G. G. Turpie, Shinya Goto, Pantep Angchaisuksiri, Jørn Dalsgaard Nielsen, Gloria Kayani, Alfredo E. Farjat, Sebastian Schellong, Henri Bounameaux, Lorenzo G. Mantovani, Paolo Prandoni, Ajay K. Kakkar, the GARFIELD-VTE investigators

05.05.2020 | COVID-19 | Letter to the Editor | Ausgabe 2/2020 Zur Zeit gratis

Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy

F. Burcu Belen-Apak, F. Sarıalioğlu

11.05.2020 | COVID-19 | Ausgabe 2/2020 Zur Zeit gratis

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia

Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri

22.05.2020 | COVID-19 | Ausgabe 2/2020 Zur Zeit gratis

Heparin resistance in COVID-19 patients in the intensive care unit

D. White, S. MacDonald, T. Bull, M. Hayman, R. de Monteverde-Robb, D. Sapsford, A. Lavinio, J. Varley, A. Johnston, M. Besser, W. Thomas

30.05.2020 | COVID-19 | Letter to the Editor | Ausgabe 2/2020 Zur Zeit gratis

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

Bingwen Eugene Fan, Yew Woon Chia, Christina Lai Lin Sum, Ponnudurai Kuperan, Stephrene Seok Wei Chan, Li Min Ling, Glenn Wei Leong Tan, Serene Si Ning Goh, Lai Har Wong, Shu Ping Lim, Kian Guan Eric Lim, Hwee Tat Tan, Mui Kia Ang, Soon Lee Lau, Kiat Hoe Ong, Jensen Ng

31.05.2020 | COVID-19 | Ausgabe 2/2020 Open Access

The association between treatment with heparin and survival in patients with Covid-19

Luis Ayerbe, Carlos Risco, Salma Ayis

05.06.2020 | COVID-19 | Ausgabe 2/2020 Zur Zeit gratis

Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients

Anna Betoule, Camille Martinet, Guillaume Gasperini, Pauline Muller, Stéphane Foucher, Patrick Benner, Aurélien Renard

25.10.2019 | Ausgabe 2/2020

Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials

Natale Daniele Brunetti, Lucia Tricarico, Michele Correale, Luisa De Gennaro, Francesco Santoro, Riccardo Ieva, Matteo Di Biase

02.12.2019 | Ausgabe 2/2020

Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis

Yunguo Zhou, Wenfeng He, Yue Zhou, Wengen Zhu

05.12.2019 | Ausgabe 2/2020

Deep vein thrombosis: a less noticed complication in hematologic malignancies and immunologic disorders

Hassan Alipanahzadeh, Reza Ghulamreza, Mohammad Shokouhian, Marziye Bagheri, Mohsen Maleknia

04.01.2020 | Ausgabe 2/2020

Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment

Maura J. Jones, Sarah T. Eudaley, Robert A. Moye, Terry A. Hodge, Ross M. Nesbit, Andrea S. Franks

09.01.2020 | Ausgabe 2/2020

Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials

Monica Verdoia, Elvin Kedhi, Harry Suryapranata, Giacomo Frati, Giuseppe Biondi-Zoccai, Giuseppe De Luca

01.02.2020 | Ausgabe 2/2020

Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience

Angelo Porfidia, Fabiana Agostini, Igor Giarretta, Diego Tonello, Daniele Pastori, Pasquale Pignatelli, Angelo Santoliquido, Michelangelo Sartori, Gianfranco Lessiani, Adriana Visonà, Marco P. Donadini, Roberto Pola

01.05.2020 | Ausgabe 2/2020

Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats

Naif O. Al-Harbi, Faisal Imam, Mohammad Matar Alharbi, Mohammad Rashid Khan, Wajhul Qamar, Muhammad Afzal, Mohammad Algahtani, Saad Alobaid, Ali Salim Alfardan, Abdulrahman Alshammari, Thamer H. Albekairi, Khalid Saad Alharbi

12.03.2020 | Ausgabe 2/2020

Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban

Ei-ichi Ueno, Kosuke Fujibayashi, Jun Sawaguchi, Yushi Yasuda, Shintaro Takano, Nakaba Fujioka, Yasuyuki Kawai, Harumi Fujita, Yoshi Tanaka, Kouji Kajinami

26.03.2020 | Ausgabe 2/2020 Open Access

Soluble platelet endothelial cell adhesion molecule 1 (sPECAM-1) improves diagnostic accuracy of D-Dimer in patients with suspected deep vein thrombosis (DVT)

Joerg Kellermair, Alexander Fellner, Alexander Bittinger, Stephanie Schneider, Kaveh Akbari, Juergen Kammler, Thomas Lambert, Clemens Steinwender

01.08.2020 | Ausgabe 2/2020 Open Access

Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States

J. D. Guo, P. Hlavacek, T. Poretta, G. Wygant, D. Lane, M. Gorritz, X. Wang, C. C. Chen, R. L. Wade, X. Pan, J. Rajpura, B. Stwalley, L. Rosenblatt

24.01.2020 | Ausgabe 2/2020

Antithrombotic therapy for atrial fibrillation with stable coronary artery disease: a meta-analysis of randomized controlled trials

Babikir Kheiri, Timothy F. Simpson, Eric C. Stecker, Mohammed Osman, Hind Rahmouni, Firas Zahr, Babak Nazer, Joaquin E. Cigarroa

29.01.2020 | Ausgabe 2/2020

Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience

Jason Filopei, Eric E. Bondarsky, Madeline Ehrlich, Marjan Islam, Gargi Bajpayee, Daniel Pang, Adil Shujaat, John Rowland, David J. Steiger

13.04.2020 | Ausgabe 2/2020

Management of periprocedural anticoagulant therapy: a novel individualized approach—a transeusophageal echocardiographic study

Eser Durmaz, Bilgehan Karadag, Baris İkitimur, Cansu Ebren, Hasan Tokdil, Damla Koca, Emre Ozmen, Fuat Polat, Kardelen Ohtaroglu Tokdil, Utku Raimoglu, Deniz Mutlu, Adem Atici, Zeki Ongen

13.02.2020 | Letter to the Editor | Ausgabe 2/2020

Superficial venous thrombosis: is it as benign as we think?

B. Lui, P. Ho, H. Y. Lim

19.02.2020 | Ausgabe 2/2020

Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation

Christina Yip, Aruni Seneviratna, Sock-Hwee Tan, Thet Khaing, Siew-Pang Chan, Joshua Loh, Chi-Hang Lee, Adrian F. Low, Chester L. Drum, Sock-Cheng Poh, C. Michael Gibson, E. Magnus Ohman, A. Mark Richards, Mark Y. Chan

09.12.2019 | Ausgabe 2/2020

ABO blood group influences risk of venous thromboembolism and myocardial infarction

Hui Pang, Zhenkun Zong, Lin Hao, Qiumei Cao

19.12.2019 | Ausgabe 2/2020

Blood type association with bleeding outcomes at delivery in a large multi-center study

Najeebah A. Bade, Jamil M. Kazma, Richard L. Amdur, Julia Ellis-Kahana, Homa K. Ahmadzia

23.01.2020 | Ausgabe 2/2020

Comparison of 2013 and 2009 versions of Caprini risk assessment models for predicting VTE in Chinese cancer patients: a retrospective study

Mei-Mei Shang, Rong Yan, Xing-Li Wang, Wei-Peng Gong, Zhen-Qing Guo

02.01.2020 | Ausgabe 2/2020

Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy

Kristin R. Smith, William E. Bryan III, Mary L. Townsend, Amy E. Randolph, Adam J. Vanderman, Catherine L. Woodard, Jamie N. Brown

01.08.2020 | Ausgabe 2/2020

Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes

Kyle A. Davis, Joel Joseph, Sarah A. Nisly

06.04.2020 | Ausgabe 2/2020

Baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database

Sharan P. Sharma, Rahul Chaudhary, Priya Gupta, Snigdha Kondur, Nitya Gatla, Sonella Blaceri, Nishit Choksi, Elias Kassab, Nistha Sareen, Ashok Kondur

25.04.2020 | Ausgabe 2/2020

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel

Plinio Cirillo, Vittorio Taglialatela, Grazia Pellegrino, Andrea Morello, Stefano Conte, Luigi Di Serafino, Giovanni Cimmino

06.05.2020 | Letter to the Editor | Ausgabe 2/2020

An unusual presentation of Idiopathic hypereosinophilic syndrome

Chun En Chua, Victor Ling, Mingxue Jing, Sai Lon Wann, Shir Ying Lee, Leonard Leong Litt Yeo, Benjamin Yong-Qiang Tan

16.05.2020 | COVID-19 | Correction | Ausgabe 2/2020 Zur Zeit gratis

Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines

Angelo Porfidia, Roberto Pola

22.06.2020 | COVID-19 | Correction | Ausgabe 2/2020 Zur Zeit gratis

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit

D. White, S. MacDonald, T. Bull, M. Hayman, D. de Monteverde-Robb, D. Sapsford, A. Lavinio, J. Varley, A. Johnston, M. Besser, W. Thomas

Aktuelle Ausgaben

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise